 |
 |

Realizing the Benefits of Practical Clinical Trials
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
To the Editor: Dr Tunis and colleagues1 discussed the need for practical clinical trials (PCTs) to better meet the information needs of clinical and health policy decision makers. While there is a growing need for rigorous effectiveness studies, we doubt that such studies alone will be sufficient. First, the conduct of PCTs will not ensure that evidence is translated into clinical practice. The poor translation of evidence into practice is illustrated by numerous examples of suboptimal quality of care despite high-quality evidence.2 Second, despite the presence of rigorous economic studies, efficiency and cost-effectiveness are infrequently incorporated into clinical practice guidelines.3 Third, clinical practice guidelines require significant effort for implementation, yet few health care settings have the necessary infrastructure. Rigorous effectiveness trials will be of little benefit until these issues are addressed.
Because manufacturers are among the largest supporters of clinical trials, there must be appropriate incentives for commercial entities to . . . [Full Text of this Article]
Joshua J. Ofman, MD, MSHS;
Deborah P. Lubeck, PhD
US Medical Affairs Amgen Inc Thousand Oaks, Calif
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLES
Realizing the Benefits of Practical Clinical TrialsReply
Sean R. Tunis and Daniel B. Stryer
JAMA. 2004;291(4):426.
EXTRACT
| FULL TEXT
Practical Clinical Trials: Increasing the Value of Clinical Research for Decision Making in Clinical and Health Policy
Sean R. Tunis, Daniel B. Stryer, and Carolyn M. Clancy
JAMA. 2003;290(12):1624-1632.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Effect of educational outreach to nurses on tuberculosis case detection and primary care of respiratory illness: pragmatic cluster randomised controlled trial
Fairall et al.
BMJ 2005;331:750-754.
ABSTRACT
| FULL TEXT
|